About Index Trending news
Analyze
Pricing
Forbion Capital Partners

Forbion Capital Partners

Work at Forbion Capital Partners? Add yourself to this profile

Forbion Capital Partners

Edit Profile
More info

Elsewhere

Contributors to this profile

Companies in the same industry

Pacific Lake Pacific Lake Mutual Capital Partners Mutual Capital Partners KPS Capital Partners KPS Capital Partners MadisonCapitalChgo MadisonCapitalChgo BGF Ventures BGF Ventures AVX Partners AVX Partners Bay Hills Capital Bay Hills Capital Castle Creek Capital Partners Castle Creek Capital Partners Defy Partners Defy Partners Julius Capital Partners Julius Capital Partners

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Investments 16
Add info
07 Feb 2017
Prexton Therapeutics SA
Prexton Therapeutics SA
€29,000,000
Venture capital (Series B)
Sunstone Capital, Forbion Capital Partners, Ysios Capital, +2

Prexton Therapeutics, participated by Ysios Capital, Series B financing round raises € 29 millions to advance its novel Parkinson’s therapeutic.es

capital-riesgo
+1
05 Jan 2017
NeRRe Therapeutics
NeRRe Therapeutics
£23,000,000
Venture capital (Series B)
Fountain Healthcare Partners, OrbiMed, Novo A/S, +2
Added by

NeRRE Therapeutics picks up Series B funds

PE Hub
+2
06 Sep 2016
Rigontec GmbH
Rigontec GmbH
€15,000,000
Venture capital (Series A)
Sunstone Capital, MP Healthcare Venture Management, NRW.BANK, +3
Added by

Rigontec Raises €15M in Third Closing of Series A Funding

FinSMEs
15 Jun 2016
Allecra Therapeutics
Allecra Therapeutics
€22,000,000
Venture capital (Series B)
EMBL Ventures, Forbion Capital Partners, Edmond de Rothschild Investment Partners, +2

Allecra Therapeutics Announces €22 Million Series B Financing

prnewswire
+1
16 Feb 2016
Akarna Therapeutics
Akarna Therapeutics
$15,000,000
Venture capital (Series B)
New Science Ventures, Third Point Ventures, Forbion Capital Partners
Added by

Akarna Therapeutics Closes $15M Series B Financing

FinSMEs
07 Jan 2016
Exosome Diagnostics
Exosome Diagnostics
$60,000,000
Venture capital (Series B)
Tiger Management Corporation, Qiagen, Arcus Ventures, +5

Exosome Diagnostics Completes $60 Million Series B Financing

businesswire
+2
02 Sep 2015
Exosome Diagnostics
Exosome Diagnostics
$17,600,000
Venture capital (Series B)
Tiger Management Corporation, CD-Venture, Arcus Ventures, +2
Added by

Exosome Diagnostics Raises $17.6 Million in Second Round Series B Financing

BioPortfolio
11 Mar 2014
Exosome Diagnostics
Exosome Diagnostics
$27,000,000
Venture capital (Series B)
b-to-v Partners AG, Qiagen, Arcus Ventures, +2
Added by

Exosome Diagnostics raises USD 27m in Series B Financing Partners AG

b-to-v
+1
25 Jul 2012
bluebird bio
bluebird bio
$60,000,000
Venture capital (Series D)
RA Capital Management, ARCH Venture Partners, Third Rock Ventures, +4
20 Apr 2011
bluebird bio
bluebird bio
$30,000,000
Venture capital
Easton Capital, ARCH Venture Partners, Third Rock Ventures, +2
04 Feb 2011
Cellnovo
Cellnovo
$48,268,413
Venture capital (Series B)
Advent Venture Partners, Auriga Partners, Crédit Agricole Private Equity, +5
04 Jan 2011
PneumRx, Inc., a BTG International group company
PneumRx, Inc., a BTG International group company
$33,000,000
Venture capital
Adams Street Partners, Endeavour Vision, Leader Ventures, +5
11 May 2010
Exosome Diagnostics
Exosome Diagnostics
$20,000,000
Venture capital (Series A)
NGN Capital, Forbion Capital Partners
Added by
12 Mar 2010
bluebird bio
bluebird bio
$35,000,000
Venture capital (Series B)
Easton Capital, Third Rock Ventures, Forbion Capital Partners, +2
30 Mar 2009
BioVex
BioVex
$40,000,000
Venture capital (Series F)
Crédit Agricole Private Equity, Scottish Equity Partners (SEP), New Science Ventures, +4